Feeling good about life may make it last a little longer. Lymphoma patients with high quality of life may live longer than those with lower life satisfaction.
Kansas City Chiefs safety Eric Berry has been diagnosed with Hodgkin lymphoma. Fortunately, his medical team has an optimistic outlook.
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.
Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.
Lymphomas are blood cancers that start in the cells of the immune system. Burkitt’s lymphoma is a particularly aggressive form of the disease. New research may have discovered a better way to treat it.
Mantle cell lymphoma is a rare, but aggressive form of blood cancer. It’s a form of non-Hodgkin lymphoma. Patients with this disease got a new treatment option today.
Pregnancy is such an exciting time in a woman’s life. She’s caring for herself and the child growing inside her. Sometimes, but not often, this bliss is interrupted with a cancer diagnosis. A recent study looked at treating blood cancers during pregnancy.